Cutaneous Cell-Mediated Delayed Hypersensitivity to Intravitreal Bevacizumab

The literature contains few reports describing autoimmune reactions to intravitreal bevacizumab and no Type-IV delayed hypersensitivity reactions. This was unexpected, as administration of intravenous bevacizumab has frequently caused dermatologic side-effects. This difference was likely attributabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Fam, Anthony, Finger, Paul T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813138/
https://www.ncbi.nlm.nih.gov/pubmed/33488016
http://dx.doi.org/10.4103/meajo.MEAJO_123_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813138/
https://www.ncbi.nlm.nih.gov/pubmed/33488016
http://dx.doi.org/10.4103/meajo.MEAJO_123_20

Ejemplares similares